|
|
|
Insider
Information: |
Avalon Ventures Vii L P |
Relationship: |
10% Owner |
City: |
La Jolla |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
7,670,442 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
7,670,442 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Akesis Pharmaceuticals |
AKESQ |
10% Owner |
2008-03-25 |
7,670,442 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2008-03-25 |
4 |
B |
$0.85 |
$2,000,001 |
D/D |
2,352,942 |
7,670,442 |
2.45 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-11-19 |
4 |
B |
$0.72 |
$14,500 |
D/D |
20,000 |
5,317,500 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-09-13 |
4 |
B |
$0.65 |
$4,925 |
D/D |
7,500 |
5,297,500 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-09-12 |
4 |
B |
$0.55 |
$8,450 |
D/D |
15,000 |
5,297,500 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-24 |
4 |
B |
$0.51 |
$2,550 |
D/D |
5,000 |
5,135,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-20 |
4 |
B |
$0.50 |
$5,050 |
D/D |
10,000 |
5,105,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-21 |
4 |
B |
$0.50 |
$28,500 |
D/D |
55,000 |
5,105,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-22 |
4 |
B |
$0.50 |
$5,050 |
D/D |
10,000 |
5,130,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-23 |
4 |
B |
$0.50 |
$7,500 |
D/D |
15,000 |
5,130,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-31 |
4 |
B |
$0.50 |
$8,750 |
D/D |
17,500 |
5,182,500 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-09-10 |
4 |
B |
$0.50 |
$13,000 |
D/D |
25,000 |
5,275,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-09-11 |
4 |
B |
$0.50 |
$6,475 |
D/D |
12,500 |
5,275,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-29 |
4 |
B |
$0.48 |
$4,800 |
D/D |
10,000 |
5,150,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-30 |
4 |
B |
$0.48 |
$7,400 |
D/D |
15,000 |
5,182,500 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-08 |
4 |
B |
$0.47 |
$2,350 |
D/D |
5,000 |
5,150,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-17 |
4 |
B |
$0.47 |
$2,350 |
D/D |
5,000 |
5,040,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-09-05 |
4 |
B |
$0.47 |
$9,500 |
D/D |
20,000 |
5,217,500 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-09-04 |
4 |
B |
$0.46 |
$7,050 |
D/D |
15,000 |
5,217,500 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-09-06 |
4 |
B |
$0.46 |
$9,550 |
D/D |
20,000 |
5,237,500 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2007-08-16 |
4 |
B |
$0.45 |
$16,300 |
D/D |
35,000 |
5,040,000 |
2.37 |
- |
|
AKESQ |
Akesis Pharmaceuticals |
10% Owner |
|
2006-11-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000,000 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|